Legal status · United States
Is Alpha-2-Macroglobulin legal in the United States?
Written by Aaron CuhaReviewed Sep 2026
Direct answer
No. Alpha-2-Macroglobulin is not an approved medicine in the United States; its classification is "Not approved; offered as an autologous blood-derived injection in some clinics". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Alpha-2-Macroglobulin in the United States at a glance
| Classification | Not approved; offered as an autologous blood-derived injection in some clinics |
|---|---|
| FDA approval status | No alpha-2-macroglobulin product is FDA approved for any indication. Injections offered in orthopaedic practice are prepared from the patient's own blood at the point of care. No approval exists for any ageing or longevity use. |
| Human studies cited | 2 of 4 citations on the profile |
| Reviewed | Sep 2026 |
Classification and note come from the Alpha-2-Macroglobulin profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
No product containing Alpha-2-Macroglobulin is approved by FDA for any use in the United States, so nothing on the market is authorized for people.
- 02
"Research use only" is a vendor label, not a legal category that permits human use. It does not exempt a product from medicines law.
- 03
Importing, supplying or promoting it for human use can fall under medicines legislation in the United States. This page is general information, not legal advice.
What Alpha-2-Macroglobulin is
A broad-spectrum plasma protease inhibitor sold as a knee injection. The one randomised trial in 75 people found it no better than platelet-rich plasma or a steroid, and the authors concluded the extra cost is not justified.
Alpha-2-macroglobulin is a large plasma protein that traps and inactivates a wide range of proteases. Two separate interests converge on it.
Mechanism: Established human biochemistry: A2M is a tetrameric plasma glycoprotein that traps proteases of all four catalytic classes in a bait-and-trap conformational change, then clears the complex through the LRP1 receptor. The joint injection rationale is that it inhibits the matrix-degrading enzymes implicated in cartilage breakdown, and a 2024 minipig study reported that A2M reduced post-traumatic cartilage damage by inhibiting inflammatory pathways.
Regulatory history: No alpha-2-macroglobulin product is FDA approved for any indication. Injections offered in orthopaedic practice are prepared from the patient's own blood at the point of care. No approval exists for any ageing or longevity use.
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Alpha-2-Macroglobulin at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Alpha-2-Macroglobulin in other countries
Frequently asked questions
Is Alpha-2-Macroglobulin legal in the United States?
No. Alpha-2-Macroglobulin is not an approved medicine in the United States; its classification is "Not approved; offered as an autologous blood-derived injection in some clinics". Nothing containing it is authorized for any use in people. Vials labeled "for research use only" are not exempt: that label does not make human use lawful. On the evidence, 2 human studies are cited on its profile.
Can I buy Alpha-2-Macroglobulin in the United States?
No approved product exists to buy. In the United States Alpha-2-Macroglobulin is classified as "Not approved; offered as an autologous blood-derived injection in some clinics", so there is no licensed pharmacy product. Vendors selling it "for research use only" are not selling it for human use, and that label does not change its legal status. This site does not list or recommend vendors.
Is Alpha-2-Macroglobulin FDA approved?
No. FDA status: No alpha-2-macroglobulin product is FDA approved for any indication. Injections offered in orthopaedic practice are prepared from the patient's own blood at the point of care. No approval exists for any ageing or longevity use.. Current US classification: "Not approved; offered as an autologous blood-derived injection in some clinics". On the evidence, 2 human studies are cited on its profile.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Alpha-2-Macroglobulin live on its compound profile.
Alpha-2-Macroglobulin profileThis page is general information about the regulatory status of Alpha-2-Macroglobulin in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.